Allmed Solutions Ltd (ALMD) - Total Assets

Latest as of December 2025: ILA31.54 Million ILA ≈ $84.57K USD

Based on the latest financial reports, Allmed Solutions Ltd (ALMD) holds total assets worth ILA31.54 Million ILA (≈ $84.57K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See ALMD book value for net asset value and shareholders' equity analysis.

Allmed Solutions Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Allmed Solutions Ltd's total assets have evolved over time, based on quarterly financial data.

Allmed Solutions Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Allmed Solutions Ltd's total assets of ILA31.54 Million consist of 96.4% current assets and 3.7% non-current assets.

Asset Category Amount (ILA) % of Total Assets
Cash & Equivalents ILA0.00 13.1%
Accounts Receivable ILA0.00 0.0%
Inventory ILA0.00 0.0%
Property, Plant & Equipment ILA0.00 0.0%
Intangible Assets ILA0.00 0.0%
Goodwill ILA0.00 0.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Allmed Solutions Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALMD company net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Allmed Solutions Ltd's current assets represent 96.4% of total assets in 2025, an increase from 90.5% in 2008.
  • Cash Position: Cash and equivalents constituted 13.1% of total assets in 2025, down from 60.8% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
  • Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Allmed Solutions Ltd Competitors by Total Assets

Key competitors of Allmed Solutions Ltd based on total assets are shown below.

Company Country Total Assets
GN Store Nord
CO:GN
Denmark Dkr29.23 Billion
Novocure Ltd
NASDAQ:NVCR
USA $1.36 Billion
Sino Medical Sciences Technology In
SHG:688108
China CN¥1.34 Billion
HOB Biotech Group Corp Ltd
SHG:688656
China CN¥965.27 Million
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
China CN¥7.51 Billion
Dirui Industrial Co Ltd
SHE:300396
China CN¥2.62 Billion
EBR Systems Inc
AU:EBR
Australia AU$97.29 Million
T&R Biofab Co. Ltd
KQ:246710
Korea ₩83.86 Billion

Allmed Solutions Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 10.31 17.24 6.95
Quick Ratio 10.31 17.24 6.68
Cash Ratio 0.00 0.00 0.00
Working Capital ILA27.44 Million ILA41.26 Million ILA35.75 Million

Allmed Solutions Ltd - Advanced Valuation Insights

This section examines the relationship between Allmed Solutions Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.28
Latest Market Cap to Assets Ratio 0.27
Asset Growth Rate (YoY) -29.6%
Total Assets ILA31.54 Million
Market Capitalization $8.53 Million USD

Valuation Analysis

Below Book Valuation: The market values Allmed Solutions Ltd's assets below their book value (0.27x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Allmed Solutions Ltd's assets decreased by 29.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Allmed Solutions Ltd (2008–2025)

The table below shows the annual total assets of Allmed Solutions Ltd from 2008 to 2025.

Year Total Assets Change
2025-12-31 ILA31.54 Million
≈ $84.57K
-29.58%
2024-12-31 ILA44.79 Million
≈ $120.09K
-24.29%
2023-12-31 ILA59.17 Million
≈ $158.63K
+2.41%
2022-12-31 ILA57.77 Million
≈ $154.89K
+5.44%
2021-12-31 ILA54.80 Million
≈ $146.90K
-2.78%
2020-12-31 ILA56.36 Million
≈ $151.10K
-16.14%
2019-12-31 ILA67.20 Million
≈ $180.17K
+55.97%
2018-12-31 ILA43.09 Million
≈ $115.52K
-16.90%
2017-12-31 ILA51.85 Million
≈ $139.02K
-0.70%
2016-12-31 ILA52.22 Million
≈ $140.00K
-8.31%
2015-12-31 ILA56.95 Million
≈ $152.69K
+27.00%
2014-12-31 ILA44.85 Million
≈ $120.23K
+2.85%
2013-12-31 ILA43.60 Million
≈ $116.90K
-45.85%
2012-12-31 ILA80.52 Million
≈ $215.88K
+1.22%
2011-12-31 ILA79.55 Million
≈ $213.28K
+122.37%
2010-12-31 ILA35.78 Million
≈ $95.91K
+211.66%
2009-12-31 ILA11.48 Million
≈ $30.77K
-25.86%
2008-12-31 ILA15.48 Million
≈ $41.51K
--

About Allmed Solutions Ltd

TA:ALMD Israel Medical Devices
Market Cap
$8.53 Million
ILA3.18 Billion ILA
Market Cap Rank
#27422 Global
#395 in Israel
Share Price
ILA33.10
Change (1 day)
-2.07%
52-Week Range
ILA28.00 - ILA40.50
All Time High
ILA186.00
About

Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more